| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e985cbce13517db85d61af7870393dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9c05f9b0c423bc97e5c00215a461387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9853cbe94259074248a8a26c5fed01aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8eded1ce8f6f6bb96e06c890033620e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60f71abac05b400e8504f8646445ca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ea64482054a10e0c6af7f120a34495a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dea939ad2973bcd5a053acc37a3e998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d33ce2c67889f391f53c6c84f80d7fb1 |
| publicationDate |
2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016179547-A1 |
| titleOfInvention |
Development of novel automated screening method for detection of fviii inhibitors |
| abstract |
Disclosed herein are methods for determining the presence of a coagulation inhibitor in a patient. A patient curve associated with the patient sample and having a patient slope (Ps) and a a standard curve associated with a control sample and having a control slope (Cs) are generated, and the Ps and the Cs are compared to obtain a Ps/Cs parallelism ratio. A Ps/Cs parallelism ratio of less than a predetermined ratio is indicative of presence of a coagulation inhibitor in the patient sample. |
| priorityDate |
2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |